Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNAEY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,247
Award facts
- Contract value 100% obligated
- $14,247.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,247.32 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support agreement running through December 2026 that enables AmerisourceBergen to supply medications and medical commodities to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as part of its extensive portfolio supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's DLA contracts demonstrate consistent capability in delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. Dupixent is a biologic medication commonly prescribed for conditions such as atopic dermatitis, moderate-to-severe asthma, and chronic rhinosinusitis with nasal polyps, making this supply essential to military medical readiness and treatment protocols.
Quick answers
Who was awarded contract SPE2DB25FNAEY?
SPE2DB25FNAEY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FNAEY worth?
The government has obligated $14,247 on SPE2DB25FNAEY.
Is contract SPE2DB25FNAEY an order under another contract?
Yes. SPE2DB25FNAEY is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAEY competed?
The extent of competition for SPE2DB25FNAEY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award